Infectious diseases Archives - Page 30 of 33

Infectious diseases

Clinical Articles

Aged care visitor guidelines balance residents’ rights and coronavirus risk – but may be hard to implement

These deaths show how fatal and fast the spread of the infection can be, and the extreme challenge of containing the virus once a positive case appears in aged care homes.

Expert/s: Prof Yun-Hee Jeon

Infectious diseases

Clinical Articles

The Real Story on a COVID-19 vaccine

Based on our knowledge about immunisation against other coronaviruses both in animals and humans, if we do get a vaccine against SARS-CoV-2, it is unlikely to be highly immunogenic or confer long-term immunity.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

Determining immunity to COVID-19

The WHO has issued a warning against assuming people who have been infected with SARS-CoV-2 in the past are immune against re-infection, even if antibodies are detected serologically.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

CovidSafe tracking app reviewed

About 1.13 million people had downloaded the federal government’s COVIDSafe app by 6am today, just 12 hours after its release last night, said Health Minister Greg Hunt. The government is hoping at least 40% of the population will make use of the app, designed to help reduce the spread of the coronavirus disease.

Expert/s: Mahmoud Elkhodr

Infectious diseases

Clinical Articles

Australia’s COVID strategy from now

Australia’s current strategy aimed at containment and mitigation of COVID-19 is working well. Australia is in a much better place than was originally predicted according to early modelling.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

Why Hong Kong is winning against COVID-19

On Monday April 20, Hong Kong reported no new cases of COVID-19, one of very few places around the world to have recorded such a great negative at this stage in the pandemic.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

What will a COVID exit strategy look like?

As the COVID-19 curve starts to flatten in Australia and New Zealand, people are rightly wondering how we will roll back current lockdown policies. Australia’s federal health minister Greg Hunt says Australia is looking to South Korea, Japan and Singapore to inform our exit strategy. New Zealand is relaxing some measures from next week.

Expert/s: Toby Phillips

Infectious diseases

Clinical Articles

Children and COVID-19

It is the world-wide experience that children appear to be at low risk of experiencing symptomatic COVID-19. Because of the low numbers, there are still a number of unanswered questions with regard to the transmission and expression of the disease in this population. Many studies are currently underway, but Professor Crawford outlines the current understanding about COVID-19 in children:

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

Osteoporosis Management during COVID-19

Throughout the coming months, people living with osteoporosis will require ongoing treatment, and it is critical patients remain fully compliant with their medication and treatment for managing osteoporosis and bone health.

Expert/s: Osteoporosis Australia

Infectious diseases

Clinical Articles

Practical GP PPE

While there is little robust clinical evidence to guide the most appropriate choice and use of PPE in general practice, particularly in relation to COVID-19, knowledge about the nature of this virus can help direct efforts to prevent its spread.

Expert/s: Dr Linda Calabresi

Infectious diseases

Clinical Articles

How long do you remain infectious when you have coronavirus?

One thing many of us want to know is for how long people who have SARS-CoV-2 , the virus that causes COVID-19, are able to pass it on to someone else.

Expert/s: Tambri Housen

Infectious diseases

Clinical Articles

COVID treatments – where are we?

There appears to be a myriad of potential treatments for our current health threat – COVID19. But just how real are these options? And which if any of these are likely to make it into our treatment regimens? A review just published online in JAMA gives us a neat summary of where we are up to in terms of treatment.

Expert/s: Dr Linda Calabresi

Infectious diseases

Aged care visitor guidelines balance residents’ rights and coronavirus risk – but may be hard to implement

These deaths show how fatal and fast the spread of the infection can be, and the extreme challenge of containing the virus once a positive case appears in aged care homes.

The Real Story on a COVID-19 vaccine

Based on our knowledge about immunisation against other coronaviruses both in animals and humans, if we do get a vaccine against SARS-CoV-2, it is unlikely to be highly immunogenic or confer long-term immunity.

Determining immunity to COVID-19

The WHO has issued a warning against assuming people who have been infected with SARS-CoV-2 in the past are immune against re-infection, even if antibodies are detected serologically.

CovidSafe tracking app reviewed

Australia’s COVID strategy from now

Australia’s current strategy aimed at containment and mitigation of COVID-19 is working well. Australia is in a much better place than was originally predicted according to early modelling.

Why Hong Kong is winning against COVID-19

On Monday April 20, Hong Kong reported no new cases of COVID-19, one of very few places around the world to have recorded such a great negative at this stage in the pandemic.

What will a COVID exit strategy look like?

Children and COVID-19

Osteoporosis Management during COVID-19

Throughout the coming months, people living with osteoporosis will require ongoing treatment, and it is critical patients remain fully compliant with their medication and treatment for managing osteoporosis and bone health.

Practical GP PPE

While there is little robust clinical evidence to guide the most appropriate choice and use of PPE in general practice, particularly in relation to COVID-19, knowledge about the nature of this virus can help direct efforts to prevent its spread.

How long do you remain infectious when you have coronavirus?

One thing many of us want to know is for how long people who have SARS-CoV-2 , the virus that causes COVID-19, are able to pass it on to someone else.

COVID treatments – where are we?

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.

Infectious diseases

These deaths show how fatal and fast the spread of the infection can be, and the extreme challenge of containing the virus once a positive case appears in aged care homes.

Based on our knowledge about immunisation against other coronaviruses both in animals and humans, if we do get a vaccine against SARS-CoV-2, it is unlikely to be highly immunogenic or confer long-term immunity.

The WHO has issued a warning against assuming people who have been infected with SARS-CoV-2 in the past are immune against re-infection, even if antibodies are detected serologically.

Australia’s current strategy aimed at containment and mitigation of COVID-19 is working well. Australia is in a much better place than was originally predicted according to early modelling.

On Monday April 20, Hong Kong reported no new cases of COVID-19, one of very few places around the world to have recorded such a great negative at this stage in the pandemic.

Throughout the coming months, people living with osteoporosis will require ongoing treatment, and it is critical patients remain fully compliant with their medication and treatment for managing osteoporosis and bone health.

While there is little robust clinical evidence to guide the most appropriate choice and use of PPE in general practice, particularly in relation to COVID-19, knowledge about the nature of this virus can help direct efforts to prevent its spread.

One thing many of us want to know is for how long people who have SARS-CoV-2 , the virus that causes COVID-19, are able to pass it on to someone else.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

Tune in for "Facial rashes case studies - Practical guide to assessment and management" lecture

Tuesday 9th June, 7pm - 9pm AEST

Speaker

Dr Philip Tong

Consultant Dermatologist; Founder, DermScreen, Dermatology Junction; Visiting Medical Officer, St Vincent’s Hospital Sydney

What does it mean when a facial red rash does not respond to topical steroids and gets worse with the treatment? Dermatologist Dr Philip Tong presents a series of cases with this scenario.